YK11 10mg

YK11 10mg

  • Brand: Dragon Pharma
  • Product Code: YK11 10mg
  • Availability: In Stock
  • $110.00



Manufacturer: Dragon Pharma
Pharmaceutical name: Myostatin
Pack: 1 pack (100 tabs (10 mg))
YK11 is a synthetic steroidal selective androgen receptor modulator (steroidal SARM). It is a steroid compound derived from 5-α-dihydrotestosterone (DHT) and acts as a gene-selective partial agonist for the androgen receptor (AR). 
 
Currently, YK11 is the only SARM known to enhance the expression of the activin binding protein Follistatin (FST), and the consequent elevation of FST is crucial for its anabolic properties. 
YK11 seeks to boost Follistatin levels by inhibiting Myostatin, which is effective in preserving muscle mass since Myostatin promotes muscle loss. This leads to elevated Follistatin levels, which significantly fosters substantial muscle growth. 
 
Increased muscle mass:
YK11 is a potent myostatin inhibitor, resulting in enhanced muscle mass. This characteristic makes it an excellent supplement for individuals aiming to increase size and strength.
 
Improved bone density:
Clinical trials have demonstrated that YK11 improves bone density. This effect is likely due to its capacity to elevate follistatin production, as follistatin interacts with the androgen receptor and counteracts myostatin's effects.
 
Reduced fat mass:
YK11 has also been found to aid in reducing fat mass, making it a viable option for those seeking to lose weight.
 
Increased strength:
YK11 may help enhance strength, allowing for heavier lifting and quicker achievement of fitness objectives.
 
Improved metabolism without affecting essential nutrients like protein or carbohydrates:
YK11 can enhance your metabolism, enabling you to burn more calories during workouts. Notably, this compound does not lead to increased lactate production, which means it won’t negatively impact performance or endurance.
 
Potential assistance for those with osteoporosis:
As previously noted, YK11 has shown the ability to increase bone density in clinical studies. This positions it as a prospective treatment for individuals dealing with bone mineral density (BMD) issues or osteoporosis.
 
Dosage: Men 5-10 mg/day
 
Half Life: 12-24 hours